Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-27 @ 11:54 PM
Study NCT ID:
NCT01349660
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2011-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-29
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-25
First Submit QC Date:
None
Study First Post Date:
2011-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-30
Results First Submit QC Date:
None
Results First Post Date:
2018-01-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-08
Last Update Post Date:
2020-06-17
Last Update Post Date Type:
ACTUAL